var data={"title":"Extraintestinal Entamoeba histolytica amebiasis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Extraintestinal Entamoeba histolytica amebiasis</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/contributors\" class=\"contributor contributor_credentials\">Karin Leder, MBBS, FRACP, PhD, MPH, DTMH</a></dd><dd><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/contributors\" class=\"contributor contributor_credentials\">Peter F Weller, MD, MACP</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/contributors\" class=\"contributor contributor_credentials\">Edward T Ryan, MD, DTMH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/contributors\" class=\"contributor contributor_credentials\">Elinor L Baron, MD, DTMH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Dec 05, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Amebiasis is caused by the protozoan <em>Entamoeba histolytica</em>. Most infections are asymptomatic; clinical manifestations include amebic dysentery and extraintestinal disease. Extraintestinal manifestations include amebic liver abscess and other more rare manifestations such as pulmonary, cardiac, and brain involvement [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/1\" class=\"abstract_t\">1</a>].</p><p>The extraintestinal manifestations of amebiasis will be reviewed here. Issues related to intestinal infection with <em>E. histolytica</em> are discussed separately, including epidemiology, pathogenesis, clinical manifestations, diagnosis, treatment, and prevention. (See <a href=\"topic.htm?path=intestinal-entamoeba-histolytica-amebiasis\" class=\"medical medical_review\">&quot;Intestinal Entamoeba histolytica amebiasis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">AMEBIC LIVER ABSCESS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Amebic liver abscess is the most common extraintestinal manifestation of amebiasis. Amebae establish hepatic infection by ascending the portal venous system [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/2\" class=\"abstract_t\">2</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Epidemiology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Amebic liver abscess (and other extraintestinal disease) is 7 to 10 times more common among adult men than other demographic groups, despite equal gender distribution of colonic amebic disease [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/3-7\" class=\"abstract_t\">3-7</a>]. It is observed most frequently in the fourth and fifth decades of life [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/8\" class=\"abstract_t\">8</a>]. The reasons for these observations are not fully understood; suggested mechanisms include hormonal effects and a potential role of alcoholic hepatocellular damage in creating a nidus for portal seeding [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/4\" class=\"abstract_t\">4</a>].</p><p>In developed countries, amebiasis is generally seen in migrants from and travelers to endemic areas. Areas with high rates of amebic infection include India, Africa, Mexico, and parts of Central and South America. Amebiasis is relatively uncommon among short-term travelers, but amebic liver abscesses can occur after travel exposures as short as four days [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/9\" class=\"abstract_t\">9</a>]. In one study, 35 percent of travelers with amebic liver abscess had spent less than six weeks in an endemic area [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/10\" class=\"abstract_t\">10</a>]. Sexual oral-anal contact may also account for acquisition of infection [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/7\" class=\"abstract_t\">7</a>].</p><p>Factors predisposing to progression from intestinal amebiasis to amebic liver abscess are not fully understood. Conditions that affect cell-mediated immunity increase the chances that <em>E. histolytica</em> infection results in invasive disease with liver involvement. It has been suggested by some that immunosuppression secondary to HIV may increase the likelihood of presenting with invasive amoebiasis, including with an amebic liver abscess [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/11\" class=\"abstract_t\">11</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Clinical manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For individuals returning from an endemic area, the clinical presentation typically occurs within 8 to 20 weeks (median 12 weeks). However, a longer interval of many years (even decades) prior to onset of clinical manifestations has been described; one report noted an average interval of 17 months [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/10,12-15\" class=\"abstract_t\">10,12-15</a>]. Patients with amebic liver abscess usually present with one to two weeks of right upper quadrant pain and fever (38.5 to 39.5&ordm;C). Pain may be referable to the epigastrium, the right chest, or the right shoulder. The pain is usually dull but may be pleuritic or aching. Other symptoms may include cough, sweating, malaise, weight loss, anorexia, and hiccough. Concurrent diarrhea is present in less than one-third of patients, although some patients report history of dysentery within the previous few months. Jaundice occurs in less than 10 percent of patients [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/16\" class=\"abstract_t\">16</a>]. Physical examination reveals hepatomegaly and point tenderness over the liver in approximately 50 percent of cases.</p><p>Rupture of liver abscess can occur into any adjoining space or organ; extension into the chest occurs almost four times as often as extension into the peritoneal cavity. In up to 7 percent of cases, the abscess ruptures into the peritoneum, causing peritonitis [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/17\" class=\"abstract_t\">17</a>]. Hepatic vein and inferior vena cava thrombosis secondary to amebic liver abscess have also been described [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/18\" class=\"abstract_t\">18</a>].</p><p>Occasionally, patients have a more chronic presentation with months of fever, weight loss, and abdominal pain with or without hepatomegaly. Recurrent episodes of infection over many years (despite adequate treatment) has also been described [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/19\" class=\"abstract_t\">19</a>].</p><p>In a study comparing the presentations of HIV-infected and HIV-uninfected patients with amebic liver abscess, no differences in clinical manifestations or radiographic findings between the two groups were observed [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/20\" class=\"abstract_t\">20</a>].</p><p>Patients with amebic liver abscess often have a leukocytosis <span class=\"nowrap\">(&gt;10,000/mm<sup>3</sup>)</span> without eosinophilia. Liver function testing demonstrates an elevated alkaline phosphatase (80 percent of cases), and hepatic transaminases may also be elevated. Other common nonspecific findings include an abnormal chest radiograph and proteinuria. (See <a href=\"#H6\" class=\"local\">'Imaging'</a> below.)</p><p>Uncommonly, patients with amebic hepatic abscesses may also have localized colonic infection resulting in a mass of granulation tissue forming an ameboma, which may mimic colon cancer [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/21,22\" class=\"abstract_t\">21,22</a>]. Patients with amebomas usually are found to have a tender palpable mass. (See <a href=\"topic.htm?path=intestinal-entamoeba-histolytica-amebiasis#H5\" class=\"medical medical_review\">&quot;Intestinal Entamoeba histolytica amebiasis&quot;, section on 'Clinical manifestations'</a>.)</p><p>Other rare complications include hepatic vein and inferior vena cava thrombosis; these have been attributed to mechanical compression and inflammation associated with a large abscess [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/23\" class=\"abstract_t\">23</a>].</p><p>Patients with secondary cardiac or pulmonary involvement may present with symptoms primarily due to these complications. (See <a href=\"#H14\" class=\"local\">'Other extraintestinal sites'</a> below.)</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Amebic liver abscess should be suspected in the setting of fever and right upper quadrant pain together with relevant epidemiology (resident in, migration from, or travel to an endemic area). In such circumstances, the diagnosis may be supported by radiographic imaging of the liver. In the setting of suggestive findings on imaging studies, confirmatory serologic or antigenic testing should be pursued, perhaps supplemented with stool microscopy or antigenic testing of stool, with or without evaluation for the parasite in liver abscess fluid. However, simultaneous liver abscess and amebic colitis is uncommon, so stool microscopy and polymerase chain reaction (PCR) are usually negative in the setting of liver abscess [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/6\" class=\"abstract_t\">6</a>].</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h3\">Imaging</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Radiographic imaging of the liver can be pursued with ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI). Ultrasonography usually demonstrates a cystic intrahepatic cavity. Amebic liver abscesses are most commonly found in the posterior part of the right lobe; 70 to 80 percent are solitary subcapsular lesions, although multiple lesions can be present [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/6,24\" class=\"abstract_t\">6,24</a>]. Localization in the left lobe predisposes to extension into the pericardial sac. (See <a href=\"#H16\" class=\"local\">'Cardiac infection'</a> below.)</p><p>On ultrasound, the abscess appears as a round, well-defined hypoechoic mass (<a href=\"image.htm?imageKey=ID%2F71420\" class=\"graphic graphic_diagnosticimage graphicRef71420 \">image 1</a>) [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/25\" class=\"abstract_t\">25</a>]. On CT scan, it appears as a low-density mass with a peripheral enhancing rim. On MRI, the abscess appears as low-signal intensity on T1-weighted images and high-signal intensity on T2-weighted images. After healing, the periphery of the abscess may calcify as a thin, round ring [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/25\" class=\"abstract_t\">25</a>].</p><p>On gallium citrate and technetium-labeled sulfur colloid radionuclide liver scans, amebic abscesses are &quot;cold&quot; (with a bright rim in some cases), whereas pyogenic abscesses are &quot;hot.&quot; Radiographic findings must be interpreted in the appropriate clinical context with consideration of the differential diagnoses, including pyogenic abscess and malignancy.</p><p>Serial imaging is generally not helpful since lesions may appear to increase in size or number on ultrasound following initiation of treatment, even with appropriate therapy and clinical improvement [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/26\" class=\"abstract_t\">26</a>]. Treated lesions may become anechoic, calcified, or may persist as cystic-appearing lesions. Complete radiologic resolution may take two years or more. Therefore, persistent abnormalities on ultrasound imaging should not prompt retreatment or additional testing in a patient who is clinically well.</p><p>A chest radiograph abnormality will be observed in approximately 50 percent of patients with an amebic liver abscess, most commonly elevation of the right hemidiaphragm [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/27\" class=\"abstract_t\">27</a>]. This finding does not necessarily signal pulmonary involvement in the infection.</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h3\">Serology and antigen detection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Approximately 99 percent of patients with amebic liver abscess develop detectable antibodies, but serologic testing may be negative in the first seven days [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/12,17,24\" class=\"abstract_t\">12,17,24</a>]. Serum antibodies are detectable in 92 to 97 percent of patients at the time of presentation.</p><p>In endemic areas, up to 35 percent of uninfected individuals have anti-amebic antibodies due to previous infection with <em>E. histolytica</em> [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/28\" class=\"abstract_t\">28</a>]. Therefore, negative serology is helpful for exclusion of disease, but positive serology cannot distinguish between acute and previous infection [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/9\" class=\"abstract_t\">9</a>].</p><p>New serologic tests based on recombinant <em>E. histolytica</em> antigens have been developed. In one study of two different antigens among 20 patients with known amebic liver abscesses, patients lost seroreactivity with the recombinant antigens more rapidly than with conventional serologic tests; such assays may be especially useful in endemic areas. [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/29\" class=\"abstract_t\">29</a>]. In another study, the combined diagnostic efficacy of indirect ELISAs using crude soluble antigen and excretory-secretory antigen for serodiagnosis of amebic liver abscess was improved by using both assays (as compared with either single assay) [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/30\" class=\"abstract_t\">30</a>].</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h3\">Aspiration</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Needle aspiration under ultrasound or CT guidance or insertion of a pigtail catheter are not routinely required but may be warranted if the cyst appears to be at imminent risk of rupture (particularly for lesions in the left lobe), if there is clinical deterioration or lack of response to empiric therapy, or if exclusion of alternative diagnoses is needed [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/31\" class=\"abstract_t\">31</a>]. In some cases, aspiration may be therapeutic as well as diagnostic [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/32,33\" class=\"abstract_t\">32,33</a>].</p><p>Amebic liver abscesses contain acellular, proteinaceous debris, and a brown fluid likened to &quot;anchovy paste,&quot; consisting predominantly of necrotic hepatocytes. Trophozoites are seen on microscopy of the aspirate in fewer than 20 percent of cases and are often present only in the peripheral parts of the abscess, invading and destroying adjacent tissue [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/34\" class=\"abstract_t\">34</a>]. This is in contrast to aspirates from pyogenic liver abscesses in which bacterial organisms and polymorphonuclear cells are usually readily apparent by Gram stain. (See <a href=\"topic.htm?path=pyogenic-liver-abscess\" class=\"medical medical_review\">&quot;Pyogenic liver abscess&quot;</a>.)</p><p>Antigen testing <span class=\"nowrap\">and/or</span> PCR on aspirated material may also be helpful in establishing the diagnosis [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/8,12,35,36\" class=\"abstract_t\">8,12,35,36</a>]. Multiple commercial and in-house tests have been reported, with sensitivities generally ranging from 75 to 100 percent [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/36-38\" class=\"abstract_t\">36-38</a>]. In one study comparing nested-multiplex PCR, Taqman (18S rRNA), and SYBR Green real-time PCR (16S-like rRNA) assays to detect <em>E. histolytica</em> from liver abscess pus and stool samples, the highest positivity rate was observed with Taqman; the lowest rate was observed conventional nested-multiplex PCR [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/39\" class=\"abstract_t\">39</a>].</p><p>Rarely, amebic hepatic abscesses can become secondarily infected with enteric bacteria, so aspirated fluid should also be sent for bacterial culture.</p><p class=\"headingAnchor\" id=\"H9471220\"><span class=\"h2\">Differential diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of amebic liver abscess includes:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pyogenic liver abscess &ndash; The clinical presentations of amebic liver abscess and pyogenic liver abscess are compared in the table (<a href=\"image.htm?imageKey=ID%2F115061\" class=\"graphic graphic_table graphicRef115061 \">table 1</a>). The diagnosis of pyogenic liver abscess is established by aspiration and culture of the abscess material. In the setting of clinical suspicion for amebic abscess together with confirmatory serologic or antigenic testing (with or without stool testing), aspiration is not usually required to rule out pyogenic liver abscess. (See <a href=\"topic.htm?path=pyogenic-liver-abscess\" class=\"medical medical_review\">&quot;Pyogenic liver abscess&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Echinococcal disease &ndash; Both <em>Echinococcus </em>and amebic liver abscess present with liver lesions; symptoms of <em>Echinococcus </em>are unusual before the cyst reaches 10 cm. <em>Echinococcus</em> may be distinguished from amebic liver abscess based on imaging and serology. Aspiration is reserved for situations in which other diagnostic methods are inconclusive. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-echinococcosis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of echinococcosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Malignancy &ndash; Patients with hepatocellular carcinoma usually have no symptoms other than those related to chronic liver disease, whereas patients with amebic liver abscess usually present with right upper quadrant pain and fever. These diagnoses are distinguished based on imaging and tissue biopsy. (See <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-primary-hepatocellular-carcinoma\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of primary hepatocellular carcinoma&quot;</a>.)</p><p/><p>The differential diagnosis of solid and cystic liver lesions is discussed further separately. (See <a href=\"topic.htm?path=solid-liver-lesions-differential-diagnosis-and-evaluation\" class=\"medical medical_review\">&quot;Solid liver lesions: Differential diagnosis and evaluation&quot;</a> and <a href=\"topic.htm?path=diagnosis-and-management-of-cystic-lesions-of-the-liver\" class=\"medical medical_review\">&quot;Diagnosis and management of cystic lesions of the liver&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Treatment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For circumstances in which amebic liver abscess is suspected based on epidemiology, clinical manifestations, and radiographic findings, it is reasonable to initiate empiric treatment pending further diagnostic evaluation (including confirmatory antigenic or serologic testing and evaluation for the parasite in stool and liver abscess pus).</p><p>In general, treatment of amebic liver abscess consists of a tissue agent and a luminal agent (to eliminate intraluminal cysts). In cases of uncomplicated amebic liver abscess, there has been no benefit observed with drainage in addition to medical therapy [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/31\" class=\"abstract_t\">31</a>]. Aspiration may be warranted for patients with either a large left-lobe abscess, a lack of clinical response within five days of appropriate antimicrobial therapy, and in cases of uncertainty about the diagnosis [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/4\" class=\"abstract_t\">4</a>].</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h3\">Tissue agents</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with an amebic liver abscess should be treated with <a href=\"topic.htm?path=metronidazole-drug-information\" class=\"drug drug_general\">metronidazole</a> (500 to 750 mg orally three times daily for 7 to 10 days) or <a href=\"topic.htm?path=tinidazole-drug-information\" class=\"drug drug_general\">tinidazole</a> (2 g once daily for 5 days) [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/40-42\" class=\"abstract_t\">40-42</a>]. The cure rate with this therapy is &gt;90 percent. Shorter duration of metronidazole is not generally recommended [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/41\" class=\"abstract_t\">41</a>]. Metronidazole is well absorbed from the gastrointestinal tract; intravenous therapy offers no significant advantage as long as the patient can take oral medications and has no major defect in small bowel absorption. (See <a href=\"topic.htm?path=intestinal-entamoeba-histolytica-amebiasis#H7060848\" class=\"medical medical_review\">&quot;Intestinal Entamoeba histolytica amebiasis&quot;, section on 'Clinical approach'</a>.)</p><p>Alternatives to <a href=\"topic.htm?path=metronidazole-drug-information\" class=\"drug drug_general\">metronidazole</a> or <a href=\"topic.htm?path=tinidazole-drug-information\" class=\"drug drug_general\">tinidazole</a> include ornidazole and <a href=\"topic.htm?path=nitazoxanide-drug-information\" class=\"drug drug_general\">nitazoxanide</a> [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/41,42\" class=\"abstract_t\">41,42</a>]. Nitazoxanide (500 mg twice daily for 10 days) has been shown to be effective in a small case series [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/43\" class=\"abstract_t\">43</a>].</p><p>In the setting of slow response to <a href=\"topic.htm?path=metronidazole-drug-information\" class=\"drug drug_general\">metronidazole</a> or relapse following therapy, therapeutic aspiration, percutaneous catheter drainage, <span class=\"nowrap\">and/or</span> a prolonged course of metronidazole may be warranted.</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h3\">Luminal agents</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Following therapy for invasive amebiasis, treatment with a luminal agent to eliminate intraluminal cysts is warranted, even if stool microscopy is negative. Intraluminal infection can be treated with one of the following regimens: <a href=\"topic.htm?path=paromomycin-drug-information\" class=\"drug drug_general\">paromomycin</a> (25 to 30 <span class=\"nowrap\">mg/kg</span> per day orally in three divided doses for 7 days), diiodohydroxyquin (650 mg orally three times daily for 20 days for adults and 30 to 40 <span class=\"nowrap\">mg/kg</span> per day in three divided doses for 20 days for children), or diloxanide furoate (500 mg orally three times daily for 10 days for adults and 20 <span class=\"nowrap\">mg/kg</span> per day in three divided doses for 10 days for children). (See <a href=\"topic.htm?path=intestinal-entamoeba-histolytica-amebiasis#H7060848\" class=\"medical medical_review\">&quot;Intestinal Entamoeba histolytica amebiasis&quot;, section on 'Clinical approach'</a>.)</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Prognosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Uncomplicated amebic liver abscess has a mortality rate of &lt;1 percent if diagnosed and treated early. In one study of 135 patients with amebic liver abscess in India with overall mortality rate of 17 percent, independent risk factors for increased mortality included bilirubin level &gt;3.5 <span class=\"nowrap\">mg/dL,</span> serum albumin &lt;2.0 <span class=\"nowrap\">g/dL,</span> large volume of the abscess cavity, multiple abscesses, and encephalopathy [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/44\" class=\"abstract_t\">44</a>].</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h1\">OTHER EXTRAINTESTINAL SITES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Rarely, amebic disease involves other sites outside the liver. Lung disease, cardiac involvement, brain abscess, perinephric or splenic abscess, vaginal or uterine involvement, rectovaginal fistulae, and cutaneous disease can all occur [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/45\" class=\"abstract_t\">45</a>].</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h2\">Pleuropulmonary infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pleuropulmonary involvement following <em>E. histolytica</em> infection is relatively rare. Risk factors for development of pulmonary amebiasis include malnutrition, chronic alcoholism, and atrial septal defect with left-to-right shunt [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/46\" class=\"abstract_t\">46</a>].</p><p>Pleural manifestations may include development of a sympathetic serous effusion. Liver abscess rupture into the pleural space results in an amebic empyema; rupture into the lung can lead to consolidation, abscess formation, or a hepatobronchial fistula [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/47,48\" class=\"abstract_t\">47,48</a>]. Other mechanisms of pleural involvement include lymphatic spread from the liver through the diaphragm or hematogenous embolic spread from the liver or colon [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/46,48\" class=\"abstract_t\">46,48</a>]. Hematogenous spread is an unusual disorder and should be suspected when there is pulmonary amebiasis in the absence of hepatic disease or in noncontiguous pulmonary and hepatic disease.</p><p class=\"headingAnchor\" id=\"H10069497\"><span class=\"h3\">Clinical manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Clinical manifestations include pain, cough, hemoptysis, and dyspnea [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/49\" class=\"abstract_t\">49</a>]. The pain may be pleuritic or localized to the right upper quadrant. Cough can be nonproductive but more often is associated with expectoration of material ranging from small amounts of sputum to large amounts of amebic pus. If a hepatobronchial fistula develops, the patient may expectorate necrotic material that can include liver abscess contents; such material may have a reddish brown or &quot;anchovy sauce&quot; appearance.</p><p>The liver may not be palpably enlarged if the original abscess is high up in the right lobe or if it has been decompressed by rupture. Pulmonary consolidation is common in the right lower and middle lobes. A case of pulmonary amebiasis presenting as superior vena cava syndrome has also been reported [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/50\" class=\"abstract_t\">50</a>].</p><p class=\"headingAnchor\" id=\"H10069504\"><span class=\"h3\">Diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of amebic pleuropulmonary disease can be established by the same tests used to diagnose hepatic amebic abscesses. Amebic serology is positive in over 90 percent. (See <a href=\"#H5\" class=\"local\">'Diagnosis'</a> above.)</p><p class=\"headingAnchor\" id=\"H10069511\"><span class=\"h3\">Treatment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In general, amebic pleural effusions should be aspirated. Drained pleural effusions resolve rapidly with drainage and antimicrobial therapy, which consists of <a href=\"topic.htm?path=metronidazole-drug-information\" class=\"drug drug_general\">metronidazole</a> (750 mg orally three times daily for 7 to 10 days) or <a href=\"topic.htm?path=tinidazole-drug-information\" class=\"drug drug_general\">tinidazole</a> (2 g once daily for 5 days) [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/51\" class=\"abstract_t\">51</a>]. Most patients respond to a single course of treatment with resolution of symptoms before the end of therapy. In rare cases, a second course of metronidazole or tinidazole is need because of failure to achieve complete resolution after the initial regimen. Relapses are rare.</p><p>Treatment with a luminal agent to eliminate intraluminal cysts is also warranted. (See <a href=\"#H12\" class=\"local\">'Luminal agents'</a> above.)</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h2\">Cardiac infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cardiac involvement in amebic disease is rarer than pleuropulmonary disease. When it occurs, it usually results from rupture of a liver abscess into the pericardium, particularly in the setting of abscesses involving the left lobe of the liver [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/52\" class=\"abstract_t\">52</a>]. This can result in severe chest pain, pericardial effusion, acute pericarditis, congestive cardiac failure, pericardial tamponade, or constrictive pericarditis, with high associated mortality. Clinically, cardiac involvement may present suddenly as a purulent pericarditis with cardiac tamponade or more slowly with gradual progression of pericardial effusion [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/53\" class=\"abstract_t\">53</a>].</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h2\">Brain abscess</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cerebral amebiasis results from hematogenous spread of infection. It is characterized by abrupt onset of symptoms and rapid progression to death if untreated. Findings on computed tomography (CT) scan may consist of irregular foci without a capsule or surrounding enhancement [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/54,55\" class=\"abstract_t\">54,55</a>]. Central nervous system (CNS) abscesses due to <em>E. histolytica</em> are distinct from CNS lesions caused by free-living amebae. (See <a href=\"topic.htm?path=free-living-amebas-and-prototheca\" class=\"medical medical_review\">&quot;Free-living amebas and Prototheca&quot;</a>.)</p><p>For circumstances in which amebic brain abscess is suspected based on epidemiology, clinical manifestations, and radiographic findings, <a href=\"topic.htm?path=metronidazole-drug-information\" class=\"drug drug_general\">metronidazole</a> should be started immediately; surgical intervention for decompression <span class=\"nowrap\">and/or</span> tissue biopsy may be required. (See <a href=\"topic.htm?path=pathogenesis-clinical-manifestations-and-diagnosis-of-brain-abscess\" class=\"medical medical_review\">&quot;Pathogenesis, clinical manifestations, and diagnosis of brain abscess&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1151028672\"><span class=\"h2\">Cutaneous infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cutaneous amebiasis may be the only manifestation of infection or may occur in the setting of other organ involvement. Cutaneous disease in the perineal region is a rare manifestation of amebiasis and may manifest as painful <span class=\"nowrap\">perianal/perineal</span> ulceration [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/56\" class=\"abstract_t\">56</a>]. This clinical entity most likely results from direct inoculation from stool and is most common in infants wearing diapers [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/57\" class=\"abstract_t\">57</a>]. Perineal cutaneous amebiasis also occurs as a sexually transmitted infection in endemic areas, including among individuals who practice insertive anal intercourse [<a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/58,59\" class=\"abstract_t\">58,59</a>].</p><p class=\"headingAnchor\" id=\"H5027298\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Extraintestinal manifestations of <em>Entamoeba histolytica</em> include amebic liver abscess and more rare manifestations such as pulmonary, cardiac, and brain involvement. Amebae establish hepatic infection by ascending the portal venous system. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In developed countries, amebiasis is generally seen in migrants from and travelers to endemic areas. Amebic liver abscess (and other extraintestinal disease) is more common among adult men than other demographic groups. (See <a href=\"#H3\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with amebic liver abscess typically present with one to two weeks of right upper quadrant pain and fever. Concurrent diarrhea is present in less than one-third of patients, although some patients report history of dysentery within the previous few months. Physical examination frequently reveals hepatomegaly and point tenderness over the liver. (See <a href=\"#H4\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In the setting of relevant epidemiology and suggestive symptoms, the diagnosis of amebic liver abscess is generally established by radiographic imaging and confirmed with serologic or antigenic testing, perhaps supplemented with stool microscopy or antigenic testing of stool, with or without evaluation for the parasite in liver abscess fluid. (See <a href=\"#H5\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Needle aspiration of amebic liver abscess is not routinely required but may be warranted if the cyst appears to be at imminent risk of rupture (particularly for lesions in the left lobe), if there is clinical deterioration or lack of response to empiric therapy, or if exclusion of alternative diagnoses is needed. (See <a href=\"#H8\" class=\"local\">'Aspiration'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In general, treatment of extraintestinal amebic disease is managed with a tissue agent and a luminal agent (to eliminate intraluminal cysts). We suggest treatment of amebic liver abscess or with <a href=\"topic.htm?path=metronidazole-drug-information\" class=\"drug drug_general\">metronidazole</a> or <a href=\"topic.htm?path=tinidazole-drug-information\" class=\"drug drug_general\">tinidazole</a> (<a href=\"grade.htm?i=5\" class=\"grade\">Grade 2B</a>). We suggest subsequent treatment with <a href=\"topic.htm?path=paromomycin-drug-information\" class=\"drug drug_general\">paromomycin</a> to eliminate intraluminal cysts (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). Dosing is outlined above. (See <a href=\"#H10\" class=\"local\">'Treatment'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pleural space involvement of <em>E. histolytica</em> can occur in the setting of liver abscess rupture into the pleural space, resulting in an amebic empyema. Rupture into the lung can lead to consolidation, abscess formation, <span class=\"nowrap\">and/or</span> hepatobronchial fistula. Clinical manifestations include pain, cough, hemoptysis, and dyspnea. Cough may be productive of necrotic material that can include liver abscess contents. (See <a href=\"#H15\" class=\"local\">'Pleuropulmonary infection'</a> above and <a href=\"#H10069497\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Treatment of amebic pleural effusions should consist of aspiration and antimicrobial therapy. We suggest treatment of pulmonary infection with <a href=\"topic.htm?path=metronidazole-drug-information\" class=\"drug drug_general\">metronidazole</a> or <a href=\"topic.htm?path=tinidazole-drug-information\" class=\"drug drug_general\">tinidazole</a> (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). We suggest subsequent treatment with <a href=\"topic.htm?path=paromomycin-drug-information\" class=\"drug drug_general\">paromomycin</a> to eliminate intraluminal cysts (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). (See <a href=\"#H10069511\" class=\"local\">'Treatment'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/1\" class=\"nounderline abstract_t\">Haque R, Huston CD, Hughes M, et al. Amebiasis. N Engl J Med 2003; 348:1565.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/2\" class=\"nounderline abstract_t\">Aikat BK, Bhusnurmath SR, Pal AK, et al. The pathology and pathogenesis of fatal hepatic amoebiasis--A study based on 79 autopsy cases. Trans R Soc Trop Med Hyg 1979; 73:188.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/3\" class=\"nounderline abstract_t\">Acuna-Soto R, Maguire JH, Wirth DF. Gender distribution in asymptomatic and invasive amebiasis. Am J Gastroenterol 2000; 95:1277.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/4\" class=\"nounderline abstract_t\">Stanley SL Jr. Amoebiasis. Lancet 2003; 361:1025.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/5\" class=\"nounderline abstract_t\">Nattakom S, Serrato P, Bright T, et al. Amebic liver abscesses masquerading as pyemic abscesses. Clin Infect Dis 2001; 33:E145.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/6\" class=\"nounderline abstract_t\">Pritt BS, Clark CG. Amebiasis. Mayo Clin Proc 2008; 83:1154.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/7\" class=\"nounderline abstract_t\">Salit IE, Khairnar K, Gough K, Pillai DR. A possible cluster of sexually transmitted Entamoeba histolytica: genetic analysis of a highly virulent strain. Clin Infect Dis 2009; 49:346.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/8\" class=\"nounderline abstract_t\">Salles JM, Salles MJ, Moraes LA, Silva MC. Invasive amebiasis: an update on diagnosis and management. Expert Rev Anti Infect Ther 2007; 5:893.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/9\" class=\"nounderline abstract_t\">Aucott JN, Ravdin JI. Amebiasis and &quot;nonpathogenic&quot; intestinal protozoa. Infect Dis Clin North Am 1993; 7:467.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/10\" class=\"nounderline abstract_t\">Knobloch J, Mannweiler E. Development and persistence of antibodies to Entamoeba histolytica in patients with amebic liver abscess. Analysis of 216 cases. Am J Trop Med Hyg 1983; 32:727.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/11\" class=\"nounderline abstract_t\">Park WB, Choe PG, Jo JH, et al. Amebic liver abscess in HIV-infected patients, Republic of Korea. Emerg Infect Dis 2007; 13:516.</a></li><li class=\"breakAll\">Peterson KM, Singh U, Petri WA Jr. Enteric Amebiasis. In: Tropical Infectious Diseases: Principles, Pathogens and Practice, 3rd ed, Guerrant R, Walker DH, Weller PF (Eds), Saunders Elsevier, Philadelphia 2011. p.614.</li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/13\" class=\"nounderline abstract_t\">Nespola B, Betz V, Brunet J, et al. First case of amebic liver abscess 22&nbsp;years after the first occurrence. Parasite 2015; 22:20.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/14\" class=\"nounderline abstract_t\">Hoffbrand BI. Amoebic liver abscess presenting thirty-two years after acute amoebic dysentery. Proc R Soc Med 1975; 68:593.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/15\" class=\"nounderline abstract_t\">Lachish T, Wieder-Finesod A, Schwartz E. Amebic Liver Abscess in Israeli Travelers: A Retrospective Study. Am J Trop Med Hyg 2016; 94:1015.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/16\" class=\"nounderline abstract_t\">Maltz G, Knauer CM. Amebic liver abscess: a 15-year experience. Am J Gastroenterol 1991; 86:704.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/17\" class=\"nounderline abstract_t\">Adams EB, MacLeod IN. Invasive amebiasis. I. Amebic dysentery and its complications. Medicine (Baltimore) 1977; 56:315.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/18\" class=\"nounderline abstract_t\">Sodhi KS, Ojili V, Sakhuja V, Khandelwal N. Hepatic and inferior vena caval thrombosis: vascular complication of amebic liver abscess. J Emerg Med 2008; 34:155.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/19\" class=\"nounderline abstract_t\">Creemers-Schild D, van Genderen PJ, Visser LG, et al. Recurrent amebic liver abscesses over a 16-year period: a case report. BMC Res Notes 2016; 9:472.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/20\" class=\"nounderline abstract_t\">Wu KS, Tsai HC, Lee SS, et al. Comparison of clinical characteristics of amebic liver abscess in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. J Microbiol Immunol Infect 2008; 41:456.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/21\" class=\"nounderline abstract_t\">Stockinger ZT. Colonic ameboma: its appearance on CT: report of a case. Dis Colon Rectum 2004; 47:527.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/22\" class=\"nounderline abstract_t\">Misra SP, Misra V, Dwivedi M. Ileocecal masses in patients with amebic liver abscess: etiology and management. World J Gastroenterol 2006; 12:1933.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/23\" class=\"nounderline abstract_t\">Martin L, Burute N, Haider E, et al. Occult Amebic Liver Abscess as Cause of Extensive Inferior Vena Cava and Hepatic Vein Thrombosis. Am J Trop Med Hyg 2017; 97:1214.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/24\" class=\"nounderline abstract_t\">Katzenstein D, Rickerson V, Braude A. New concepts of amebic liver abscess derived from hepatic imaging, serodiagnosis, and hepatic enzymes in 67 consecutive cases in San Diego. Medicine (Baltimore) 1982; 61:237.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/25\" class=\"nounderline abstract_t\">Park MS, Kim KW, Ha HK, Lee DH. Intestinal parasitic infection. Abdom Imaging 2008; 33:166.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/26\" class=\"nounderline abstract_t\">Benedetti NJ, Desser TS, Jeffrey RB. Imaging of hepatic infections. Ultrasound Q 2008; 24:267.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/27\" class=\"nounderline abstract_t\">Thorsen S, R&oslash;nne-Rasmussen J, Petersen E, et al. Extra-intestinal amebiasis: clinical presentation in a non-endemic setting. Scand J Infect Dis 1993; 25:747.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/28\" class=\"nounderline abstract_t\">Joyce MP, Ravdin JI. Antigens of Entamoeba histolytica recognized by immune sera from liver abscess patients. Am J Trop Med Hyg 1988; 38:74.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/29\" class=\"nounderline abstract_t\">Stanley SL Jr, Jackson TF, Foster L, Singh S. Longitudinal study of the antibody response to recombinant Entamoeba histolytica antigens in patients with amebic liver abscess. Am J Trop Med Hyg 1998; 58:414.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/30\" class=\"nounderline abstract_t\">Wong WK, Foo PC, Olivos-Garcia A, et al. Parallel ELISAs using crude soluble antigen and excretory-secretory antigen for improved serodiagnosis of amoebic liver abscess. Acta Trop 2017; 172:208.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/31\" class=\"nounderline abstract_t\">Chavez-Tapia NC, Hernandez-Calleros J, Tellez-Avila FI, et al. Image-guided percutaneous procedure plus metronidazole versus metronidazole alone for uncomplicated amoebic liver abscess. Cochrane Database Syst Rev 2009; :CD004886.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/32\" class=\"nounderline abstract_t\">Soentjens P, Ostyn B, Clerinx J, et al. A case of multiple amoebic liver abscesses: clinical improvement after percutaneous aspiration. Acta Clin Belg 2005; 60:28.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/33\" class=\"nounderline abstract_t\">Khanna S, Chaudhary D, Kumar A, Vij JC. Experience with aspiration in cases of amebic liver abscess in an endemic area. Eur J Clin Microbiol Infect Dis 2005; 24:428.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/34\" class=\"nounderline abstract_t\">Salata RA, Ravdin JI. The interaction of human neutrophils and Entamoeba histolytica increases cytopathogenicity for liver cell monolayers. J Infect Dis 1986; 154:19.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/35\" class=\"nounderline abstract_t\">Khan U, Mirdha BR, Samantaray JC, Sharma MP. Detection of Entamoeba histolytica using polymerase chain reaction in pus samples from amebic liver abscess. Indian J Gastroenterol 2006; 25:55.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/36\" class=\"nounderline abstract_t\">Jaiswal V, Ghoshal U, Baijal SS, et al. Evaluation of antigen detection and polymerase chain reaction for diagnosis of amoebic liver abscess in patients on anti-amoebic treatment. BMC Res Notes 2012; 5:416.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/37\" class=\"nounderline abstract_t\">Roy S, Kabir M, Mondal D, et al. Real-time-PCR assay for diagnosis of Entamoeba histolytica infection. J Clin Microbiol 2005; 43:2168.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/38\" class=\"nounderline abstract_t\">Othman N, Mohamed Z, Verweij JJ, et al. Application of real-time polymerase chain reaction in detection of Entamoeba histolytica in pus aspirates of liver abscess patients. Foodborne Pathog Dis 2010; 7:637.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/39\" class=\"nounderline abstract_t\">Dinoop KP, Parija SC, Mandal J, et al. Comparison of nested-multiplex, Taqman &amp; SYBR Green real-time PCR in diagnosis of amoebic liver abscess in a tertiary health care institute in India. Indian J Med Res 2016; 143:49.</a></li><li class=\"breakAll\">Drugs for Parasitic Infections, 3rd ed, The Medical Letter, New Rochelle, NY 2013.</li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/41\" class=\"nounderline abstract_t\">Lasserre R, Jaroonvesama N, Kurathong S, Soh CT. Single-day drug treatment of amebic liver abscess. Am J Trop Med Hyg 1983; 32:723.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/42\" class=\"nounderline abstract_t\">Quaderi MA, Rahman MS, Rahman A, Islam N. Amoebic liver abscess and clinical experiences with tinidazole in Bangladesh. J Trop Med Hyg 1978; 81:16.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/43\" class=\"nounderline abstract_t\">Rossignol JF, Kabil SM, El-Gohary Y, Younis AM. Nitazoxanide in the treatment of amoebiasis. Trans R Soc Trop Med Hyg 2007; 101:1025.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/44\" class=\"nounderline abstract_t\">Sharma MP, Dasarathy S, Verma N, et al. Prognostic markers in amebic liver abscess: a prospective study. Am J Gastroenterol 1996; 91:2584.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/45\" class=\"nounderline abstract_t\">Kenner BM, Rosen T. Cutaneous amebiasis in a child and review of the literature. Pediatr Dermatol 2006; 23:231.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/46\" class=\"nounderline abstract_t\">Shamsuzzaman SM, Hashiguchi Y. Thoracic amebiasis. Clin Chest Med 2002; 23:479.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/47\" class=\"nounderline abstract_t\">Lal C, Huggins JT, Sahn SA. Parasitic diseases of the pleura. Am J Med Sci 2013; 345:385.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/48\" class=\"nounderline abstract_t\">Kunst H, Mack D, Kon OM, et al. Parasitic infections of the lung: a guide for the respiratory physician. Thorax 2011; 66:528.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/49\" class=\"nounderline abstract_t\">Kennedy D, Sharma OP. Hemoptysis in a 49-year-old man. An unusual presentation of a sporadic disease. Chest 1990; 98:1275.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/50\" class=\"nounderline abstract_t\">Lichtenstein A, Kondo AT, Visvesvara GS, et al. Pulmonary amoebiasis presenting as superior vena cava syndrome. Thorax 2005; 60:350.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/51\" class=\"nounderline abstract_t\">Fung HB, Doan TL. Tinidazole: a nitroimidazole antiprotozoal agent. Clin Ther 2005; 27:1859.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/52\" class=\"nounderline abstract_t\">Miyauchi T, Takiya H, Sawamura T, Murakami E. Cardiac tamponade due to intrapericardial rupture of an amebic liver abscess. Jpn J Thorac Cardiovasc Surg 2005; 53:206.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/53\" class=\"nounderline abstract_t\">Nunes MC, Guimar&atilde;es J&uacute;nior MH, Diamantino AC, et al. Cardiac manifestations of parasitic diseases. Heart 2017; 103:651.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/54\" class=\"nounderline abstract_t\">Maldonado-Barrera CA, Campos-Esparza Mdel R, Mu&ntilde;oz-Fern&aacute;ndez L, et al. Clinical case of cerebral amebiasis caused by E. histolytica. Parasitol Res 2012; 110:1291.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/55\" class=\"nounderline abstract_t\">Abdel Razek AA, Watcharakorn A, Castillo M. Parasitic diseases of the central nervous system. Neuroimaging Clin N Am 2011; 21:815.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/56\" class=\"nounderline abstract_t\">Maga&ntilde;a ML, Fern&aacute;ndez-D&iacute;ez J, Maga&ntilde;a M. Cutaneous amebiasis in pediatrics. Arch Dermatol 2008; 144:1369.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/57\" class=\"nounderline abstract_t\">Fern&aacute;ndez-D&iacute;ez J, Maga&ntilde;a M, Maga&ntilde;a ML. Cutaneous amebiasis: 50 years of experience. Cutis 2012; 90:310.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/58\" class=\"nounderline abstract_t\">Abdolrasouli A, de Vries HJ, Hemmati Y, et al. Sexually transmitted penile amoebiasis in Iran: a case series. Sex Transm Infect 2012; 88:585.</a></li><li><a href=\"https://www.uptodate.com/contents/extraintestinal-entamoeba-histolytica-amebiasis/abstract/59\" class=\"nounderline abstract_t\">Mor&aacute;n P, Rojas L, Cerritos R, et al. Case report: Cutaneous amebiasis: the importance of molecular diagnosis of an emerging parasitic disease. Am J Trop Med Hyg 2013; 88:186.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 5728 Version 19.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H5027298\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">AMEBIC LIVER ABSCESS</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Epidemiology</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">Clinical manifestations</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">Diagnosis</a><ul><li><a href=\"#H6\" id=\"outline-link-H6\">- Imaging</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">- Serology and antigen detection</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">- Aspiration</a></li></ul></li><li><a href=\"#H9471220\" id=\"outline-link-H9471220\">Differential diagnosis</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">Treatment</a><ul><li><a href=\"#H11\" id=\"outline-link-H11\">- Tissue agents</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">- Luminal agents</a></li></ul></li><li><a href=\"#H13\" id=\"outline-link-H13\">Prognosis</a></li></ul></li><li><a href=\"#H14\" id=\"outline-link-H14\">OTHER EXTRAINTESTINAL SITES</a><ul><li><a href=\"#H15\" id=\"outline-link-H15\">Pleuropulmonary infection</a><ul><li><a href=\"#H10069497\" id=\"outline-link-H10069497\">- Clinical manifestations</a></li><li><a href=\"#H10069504\" id=\"outline-link-H10069504\">- Diagnosis</a></li><li><a href=\"#H10069511\" id=\"outline-link-H10069511\">- Treatment</a></li></ul></li><li><a href=\"#H16\" id=\"outline-link-H16\">Cardiac infection</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">Brain abscess</a></li><li><a href=\"#H1151028672\" id=\"outline-link-H1151028672\">Cutaneous infection</a></li></ul></li><li><a href=\"#H5027298\" id=\"outline-link-H5027298\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/5728|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=ID/71420\" class=\"graphic graphic_diagnosticimage\">- Amebic liver abscess</a></li></ul></li><li><div id=\"ID/5728|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ID/115061\" class=\"graphic graphic_table\">- Liver abscess characteristics</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-diagnosis-of-primary-hepatocellular-carcinoma\" class=\"medical medical_review\">Clinical features and diagnosis of primary hepatocellular carcinoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-echinococcosis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of echinococcosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-and-management-of-cystic-lesions-of-the-liver\" class=\"medical medical_review\">Diagnosis and management of cystic lesions of the liver</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=free-living-amebas-and-prototheca\" class=\"medical medical_review\">Free-living amebas and Prototheca</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=intestinal-entamoeba-histolytica-amebiasis\" class=\"medical medical_review\">Intestinal Entamoeba histolytica amebiasis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-clinical-manifestations-and-diagnosis-of-brain-abscess\" class=\"medical medical_review\">Pathogenesis, clinical manifestations, and diagnosis of brain abscess</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pyogenic-liver-abscess\" class=\"medical medical_review\">Pyogenic liver abscess</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=solid-liver-lesions-differential-diagnosis-and-evaluation\" class=\"medical medical_review\">Solid liver lesions: Differential diagnosis and evaluation</a></li></ul></div></div>","javascript":null}